article thumbnail

You Ask, We Answer (Part 1): Questions From the California Cannabis Webinar

Canna Law Blog

I recently teamed up with my colleagues Hilary Bricken and Griffen Thorne to put on a free webinar answering all of your pressing questions about cannabis legal issues in California. The FTC has issued warning letters to companies that advertise their CBD-infused products as treatments or cures for serious medical conditions.

article thumbnail

New Jersey Greatly Expands Medical Marijuana Law

Greenspoon Marder Cannabis Law Group Blog

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. Interested parties may submit questions for regulators in advance of the NJ Department of Health webinar on August 2.If By: Kristin Jordan , Senior Counsel.

Law 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Greenspoon Marder Article: NEW JERSEY GREATLY EXPANDS MEDICAL MARIJUANA LAW

Cannabis Law Report

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. Interested parties may submit questions for regulators in advance of the NJ Department of Health webinar on August 2.If By: Kristin Jordan , Senior Counsel. Kristin Jordan.

Law 40
article thumbnail

Minorities in cannabis, with Steven Philpott Jr.

The Cannigma

We’ve got a really interesting webinar coming up later this month on February 24. And we’re going to be focusing on Black-owned and social equity-focused brands on that webinar, so be sure to sign up and tune in. But once you’ve got that extract, that extract should be homogenous, and that edible should be homogenous.

article thumbnail

Data is Knowledge with Otha Smith III

The Cannigma

Listen & Subscribe: Finding the correct dosage and combination of cannabinoid products for medical treatment is almost universally a long and expensive process of trial and error. EG: Yeah, I was also very excited, we’ve done a number of different collaborations with Otha in the past year and a half, had him on webinars.

Data 52